📰 Assertio Therapeutics News
Page 3 - Assertio Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Assertio Therapeutics. Real-time updates on events, politics, business and more.
June 24, 2022
Pixium Vision expands its Board of Directors with the appointment of Anja Krammer and August Moretti Paris, France, June 24, 2022 - 07:00 CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641
June 24, 2022
Investegate announcements from Pixium Vision, Pixium Vision expands its Board of Directors with the appointment of Anja Krammer and August Moretti
June 22, 2022
WIXOM, Mich. , June 22, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that
May 3, 2022
The latest study by Future Market Insight (FMI) provides insights into the governing factors facilitating the growth in the analgesics market. It also examines scope of expansion across various segments in terms of drug class, indication, route of administration, and distribution channel. The study also uncovers cha...
April 25, 2022
/PRNewswire/ -- UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA INCHEN HUANG, Individually and on Behalf of All Others Similarly Situated,...
April 25, 2022
WASHINGTON, April 25, 2022 /PRNewswire/ -- UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF CALIFORNIAINCHEN HUANG, Individually and on Behalf of ...
February 15, 2022
Collegium Pharmaceutical’s acquisition of BioDelivery Sciences International brings a pain drug that’s administered in a different way than its current lineup of medicines. The deal also gives Collegium a way to break into the neurology market.
January 24, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application
January 24, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): Patent24-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key...
January 24, 2022
EQS-Ad-hoc: Relief Therapeutics Holding AG / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Re...